Spironolactone
Product Images NDC 21695-960

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 21695-960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is An Image Of The Structural Formula For Spironolactone. (E5bf608e C6dd 44e8 96aa Ba4660f64de0 01)

This is not a useful description as it contains only chemical formula and molecular weight information.*

FDA Label Image

This Is Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (E5bf608e C6dd 44e8 96aa Ba4660f64de0 02)

The text describes a statistical analysis result. The log-rank p-value is less than 0.001 and there is a timeline of months from 6 to 48. It is most likely related to a survival analysis or a clinical study.*

FDA Label Image

This Is An Image Of Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (E5bf608e C6dd 44e8 96aa Ba4660f64de0 03)

FDA Label Image

Spironolactone 50mg (E5bf608e C6dd 44e8 96aa Ba4660f64de0 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.